tutorial arrow
Create your own tool library
Bookmark tools and put favorites into folders to find them easily.

Curcumin Resource Database CRDB


An integrated and curated repository of curcumin analogs and their molecular targets. CRDB also contains information of various international and national patents on curcumin and its analogs. Currently the database has 1186 curcumin analogs with their 196 molecular targets curated from public domain databases and published literature in peer reviewed journals. The CRDB web portal contains user-friendly interfaces and is expected to be highly useful to the researchers working on structure/ligand based molecular design of curcumin analogs.

User report

tutorial arrow
Vote up tools and offer feedback
Give value to tools and make your expertise visible

0 user reviews

0 user reviews

No review has been posted.

CRDB forum

tutorial arrow
Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.

No open topic.

CRDB classification

CRDB specifications

Restrictions to use:

CRDB support


  • Utpal Bora <>


tutorial arrow
Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.



Bioengineering Research Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Assam, India; Centre for Biological Sciences (Bioinformatics), Central University of South Bihar (CUSB), Patna, India; Institute of Advanced Studies on Science and Technology (IASST) Boragaon, Guwahati, Assam, India; Institutional Biotech Hub, Centre for the Environment, Indian Institute of Technology Guwahati (IITG), Assam, India

Funding source(s)

Institutional Biotech Hub (Project BT/04/NE/2009) established under Department of Biotechnology (DBT), Government of India; IASST, Guwahati, Government of India from its core research funds for web hosting

Link to literature

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.